Publisher： Bentham Science Publishers
E-ISSN： 1996-3181|15|10|1231-1239
ISSN： 1871-5273
Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.10, 2016-12, pp. : 1231-1239
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cholinergic receptors and neurodegenerative diseases
By Gualtieri F.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
Access to resources
Recommend
Chelating Agents for Neurodegenerative Diseases
Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. :
Pharmacogenomics of neurodegenerative diseases
By Maimone D. Dominici R. Grimaldi L.M.E.
European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. :
Receptors in neurodegenerative diseases
By Froestl W.
Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. :
Antioxidant strategies for neurodegenerative diseases
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. :